Search Results
You are looking at 1 - 1 of 1 items for
- Author: Xuan-Tong Liu x
- Refine by access: All content x
Laboratory for Reproductive Immunology, Key Laboratory of Reproduction Regulation of NPFPC, SIPPR, IRD, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Xuan-Tong Liu in
Google Scholar
PubMed
Search for other papers by Hui-Ting Sun in
Google Scholar
PubMed
Search for other papers by Zhong-Fang Zhang in
Google Scholar
PubMed
Search for other papers by Ru-Xia Shi in
Google Scholar
PubMed
Search for other papers by Li-Bing Liu in
Google Scholar
PubMed
Search for other papers by Jia-Jun Yu in
Google Scholar
PubMed
Search for other papers by Wen-Jie Zhou in
Google Scholar
PubMed
Search for other papers by Chun-Jie Gu in
Google Scholar
PubMed
Search for other papers by Shao-Liang Yang in
Google Scholar
PubMed
Search for other papers by Yu-Kai Liu in
Google Scholar
PubMed
Search for other papers by Hui-Li Yang in
Google Scholar
PubMed
Search for other papers by Feng-Xuan Xu in
Google Scholar
PubMed
Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Ming-Qing Li in
Google Scholar
PubMed
It has been reported that the impaired cytotoxicity of natural killer (NK) cells and abnormal cytokines that are changed by the interaction between ectopic endometrial cells and immune cells is indispensable for the initiation and development of endometriosis (EMS). However, the mechanism of NK cells dysfunction in EMS remains largely unclear. Here, we found that NK cells in peritoneal fluid from women with EMS highly expressed indoleamine 2,3-dioxygenase (IDO). Furthermore, IDO+NK cells possessed lower NKp46 and NKG2D but higher IL-10 than that of IDO-NK. Co-culture with endometrial stromal cells (nESCs) from healthy control or ectopic ESCs (eESCs) from women with EMS led to a significant increase in the IDO level in NK cells from peripheral blood, particularly eESCs, and an anti-TGF-β neutralizing antibody suppressed these effects in vitro. NK cells co-cultured with ESC more preferentially inhibited the viability of nESCs than eESCs did, and pretreating with 1-methyl-tryptophan (1-MT), an IDO inhibitor, reversed the inhibitory effect of NK cells on eESC viability. These data suggest that ESCs induce IDO+NK cells differentiation partly by TGF-β and that IDO further restricts the cytotoxicity of NK cells in response to eESCs, which provides a potential therapeutic strategy for EMS patients, particularly those with a high number of impaired cytotoxic IDO+NK cells.
